Amunix Inc.

GangaGen International LLC, located in Palo Alto, CA, is dedicated to engineering novel treatments targeting drug-resistant bacterial infections. The company focuses on developing innovative solutions, including protein antibacterials such as bacteriocins and lysins, along with bacteriophages and their novel applications. With a robust management team and scientific advisory board, GangaGen collaborates on research initiatives and provides services to advance the fight against antibiotic resistance. Their commitment to tackling critical healthcare challenges is reflected in their diverse pipeline of advanced therapeutic options. Generated from the website

Ultragenyx Pharmaceutical Inc, based in Novato, is at the forefront of rare disease medicine, dedicated to advancing the rare disease community. With a commitment to progress and innovation, Ultragenyx is shaping the future of healthcare for those with rare diseases. Driven by a mission to propel the rare disease field forward, Ultragenyx Pharmaceutical Inc is a leader in developing treatments and therapies for those in need. Their focus on rare diseases underscores their dedication to improving the lives of patients and caregivers worldwide. Generated from their website's infomation